echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > IBD: Active disease in patients with inflammatory bowel disease is a risk factor for exacerbation of new coronary pneumonia

    IBD: Active disease in patients with inflammatory bowel disease is a risk factor for exacerbation of new coronary pneumonia

    • Last Update: 2022-05-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The pathogenesis of COVID-19 is based on a delicate balance between positive and negative effects on the host's immune


    COVID-19 immunity due to the interplay between chronic inflammation, the immune response against the virus, and the effects of the immunomodulatory drugs the patient is using more complicated in patients


    Diagnostic Statistics

     

    A total of 122 patients (mean age, 43.


    ulcerative colitis

    Figure: Risk factors for exacerbation of new coronary pneumonia

    Figure: Risk factors for exacerbation of new coronary pneumonia New coronary pneumonia

    This retrospective observational study of COVID-19 patients with inflammatory bowel disease and SARS-CoV-2 infection showed that severe inflammatory bowel disease activity was the only independent risk factor for disease exacerbation in COVID-19


    This retrospective observational study of COVID-19 patients with inflammatory bowel disease and SARS-CoV-2 infection showed that severe inflammatory bowel disease activity was the only independent risk factor for disease exacerbation in COVID-19


    Original source:

    Fabio Salvatore Macaluso.


    Fabio Salvatore Macaluso.
    Et al.
    Severe Activity of Inflammatory Bowel Disease is a Risk Factor for Severe COVID-19.
    Inflammatory Bowel Diseases.
    2022.
    Severe Activity of Inflammatory Bowel Disease is a Risk Factor for Severe COVID-19.


    Leave a comment here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.